GD
Grandfield & Dodd Portfolio holdings
AUM
$1.71B
1-Year Return
14.85%
This Quarter Return
-3.42%
1 Year Return
+14.85%
3 Year Return
+57.47%
5 Year Return
+112%
10 Year Return
+284.72%
AUM
$1.62B
AUM Growth
-$65.6M
(-3.9%)
Cap. Flow
+$7.78M
Cap. Flow
% of AUM
0.48%
Top 10 Holdings %
Top 10 Hldgs %
32.21%
Holding
212
New
5
Increased
55
Reduced
70
Closed
10
Top Buys
| 1 |
Berkshire Hathaway Class A
BRK.A
|
$9.51M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
$4.4M |
| 3 |
Lamb Weston
LW
|
$2.34M |
| 4 |
Teledyne Technologies
TDY
|
$1.91M |
| 5 |
Nike
NKE
|
$1.3M |
Top Sells
| 1 |
GE Vernova
GEV
|
$5.64M |
| 2 |
Corning
GLW
|
$2.72M |
| 3 |
Merck
MRK
|
$1.66M |
| 4 |
Blackbaud
BLKB
|
$1.28M |
| 5 |
Microsoft
MSFT
|
$1.2M |
Sector Composition
| 1 | Technology | 28.41% |
| 2 | Industrials | 17.21% |
| 3 | Healthcare | 16.4% |
| 4 | Financials | 10.25% |
| 5 | Consumer Staples | 7.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Ionis Pharmaceuticals
IONS
$9.46B
| $1.25M | 0.08% |
35,887
+1,074
| +3% | +$37.5K |
|
102
iShares Russell 1000 ETF
IWB
$43.5B
| $1.2M | 0.07% |
3,723
| – | – |
|
103
Tesla
TSLA
$1.09T
| $1.16M | 0.07% |
2,877
| – | – |
|
104
BioMarin Pharmaceuticals
BMRN
$10.9B
| $1.14M | 0.07% |
17,392
+731
| +4% | +$48K |
|
105
McDonald's
MCD
$226B
| $1.1M | 0.07% |
3,802
| – | – |
|
106
Visa
V
$681B
| $1.09M | 0.07% |
3,435
| – | – |
|
107
Waters Corp
WAT
$17.8B
| $1.08M | 0.07% |
2,910
| – | – |
|
108
Union Pacific
UNP
$132B
| $1M | 0.06% |
4,398
| – | – |
|
109
AbbVie
ABBV
$376B
| $983K | 0.06% |
5,532
| – | – |
|
110
Eaton
ETN
$136B
| $977K | 0.06% |
2,944
-50
| -2% | -$16.6K |
|
111
Kimberly-Clark
KMB
$42.9B
| $866K | 0.05% |
6,610
-150
| -2% | -$19.7K |
|
112
Jacobs Solutions
J
$17.2B
| $865K | 0.05% |
6,538
| – | – |
|
113
John Wiley & Sons Class A
WLY
$2.04B
| $826K | 0.05% |
18,887
-4,230
| -18% | -$185K |
|
114
H.B. Fuller
FUL
$3.31B
| $798K | 0.05% |
11,824
| – | – |
|
115
Philip Morris
PM
$251B
| $780K | 0.05% |
6,484
| – | – |
|
116
Vanguard Health Care ETF
VHT
$15.6B
| $772K | 0.05% |
3,045
| – | – |
|
117
Invesco S&P 500 Equal Weight ETF
RSP
$74B
| $750K | 0.05% |
4,280
+800
| +23% | +$140K |
|
|
118
Blackbaud
BLKB
$3.22B
| $736K | 0.05% |
9,960
-17,350
| -64% | -$1.28M |
|
119
Bristol-Myers Squibb
BMY
$95B
| $733K | 0.05% |
12,954
-65
| -0.5% | -$3.68K |
|
120
Novo Nordisk
NVO
$249B
| $730K | 0.05% |
8,484
-50
| -0.6% | -$4.3K |
|
121
Exelixis
EXEL
$10.1B
| $728K | 0.04% |
21,866
+9,846
| +82% | +$328K |
|
122
Fiserv
FI
$74B
| $708K | 0.04% |
3,446
| – | – |
|
123
Genmab
GMAB
$16.8B
| $704K | 0.04% |
33,733
+1,370
| +4% | +$28.6K |
|
124
NextEra Energy, Inc.
NEE
$146B
| $703K | 0.04% |
9,806
| – | – |
|
125
Walmart
WMT
$805B
| $676K | 0.04% |
7,479
| – | – |
|